Darmiyan, Inc., a San Francisco, CA-based developer of brain diagnostics, raised $6M in the initial closing of a seed funding.
The round was led by Eisai with participation from IT-Farm and Y-Combinator (YC).
Led by Padideh Kamali-Zare, PhD, president and founder CEO, Darmiyan provides AI-Powered virtual microscope BrainSee, its novel and proprietary technology (US patent 10573414) that provides a solution for early diagnosis, monitoring, and stratification of Alzheimer’s disease. BrainSee’s AI-powered algorithm takes the currently available standard clinical brain MRI and basic cognitive tests and generates brain maps and scores that indicate pathology at the earliest stages of the disease when treatments are feasible.
The software is now being tested in major memory clinics and hospitals in the US and Canada through partnership with CABHI (Centre for Aging and Brain Health Innovation, powered by Baycrest Institute).